Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05660525 · ClinicalTrials.gov registry record · NA
Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in Appalachia
A NA study of Smoking Cessation and Smoking, sponsored by University of Virginia.
- Recruiting
- Registry status
- NA
- Development phase
- 768
- Enrollment target
- 1
- Study location
NCT05660525: Recruiting NA study of Smoking Cessation and Smoking, sponsored by University of Virginia.
NCT05660525 is a NA study of Smoking Cessation and Smoking that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 768 participants, above the 471-participant average among 188 other Smoking Cessation trials with a reported enrollment target (63% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05660525, a NA study of Smoking Cessation and Smoking, is actively recruiting participants, sponsored by University of Virginia.
- RECRUITING
- Registry status
- NA
- Development phase
- 768 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to evaluate the effectiveness and implementation of a pharmacist-delivered MTM (medication therapy management) approach, called QuitAid, to quitting cigarette smoking in rural Appalachia. The main questions it aims to answer are: * Is QuitAid, alone or combined with other quitting tobacco treatments, effective? * What makes QuitAid easy or hard to carry out? Is it cost effective? Is it easy to maintain? Treatment: All participants will be given at least 4 weeks of the nicotine patch. Some participants will be randomized (like the flip of a coin) to receive additional treatments (listed below). These groups will be compared to each other to see which combination works best to help them quit smoking. * Smokefree TXT - a texting program that helps people quit smoking * Tobacco quitline - 4 phone sessions to help people quit smoking * 8 weeks of NRT (nicotine replacement therapy in the form of nicotine patches or nicotine patches and lozenge) medication instead of 4 weeks * QuitAid - An MTM program given by the patient's pharmacist. This is a quitting smoking coaching program * Nicotine patch AND nicotine lozenge instead of just nicotine patches
Primary Outcome
The primary outcome is biochemically verified point prevalence (verified through a CO test via Smokerlyzer at endpoint of participation in trial) abstinence defined as no smoking (even a puff) within the past 7 days.
Conditions Studied
Interventions
- DRUG 4 weeks of Nicotine lozenge
- DRUG 8 weeks of Nicotine Replacement Therapy Patch
- BEHAVIORAL QuitAid
- BEHAVIORAL Smokefree TXT
- BEHAVIORAL Tobacco Quitline
Study Locations (1)
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 768 participants |
| Start Date | 2024-03-06 |
| Est. Completion | 2028-03-01 |
| Phase | NA |
What NCT05660525 shows while recruiting
NCT05660525 is an interventional study that assigns participants to a tested intervention. The registered 768 participants enrollment target is mid-sized for trials with a published cap, above the 471-participant average among 188 other Smoking Cessation trials with a reported enrollment target (63% higher).
The record links to 6 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 5 interventions - of which 4 weeks of Nicotine lozenge is the first listed.
NCT05660525 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT05660525 about?
NCT05660525 is a clinical study titled "Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in Appalachia". The goal of this clinical trial is to evaluate the effectiveness and implementation of a pharmacist-delivered MTM (medication therapy management) approach, called QuitAid, to quitting cigarette smoking in rural Appalachia. The main questions it aims to answer are: * Is QuitAid, alone or combined w...
What is the current status of trial NCT05660525?
This trial is currently recruiting. It is a NA study. The enrollment target is 768 participants. The study started on 2024-03-06. Estimated completion is 2028-03-01.
What conditions does trial NCT05660525 study?
This clinical trial studies the following conditions: Smoking Cessation, Smoking, Smoking, Cigarette, Smoking, Tobacco, Smoking Reduction.
What interventions are being tested in trial NCT05660525?
The interventions under investigation include: 4 weeks of Nicotine lozenge (DRUG), 8 weeks of Nicotine Replacement Therapy Patch (DRUG), QuitAid (BEHAVIORAL), Smokefree TXT (BEHAVIORAL), Tobacco Quitline (BEHAVIORAL).
Who is sponsoring clinical trial NCT05660525?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05660525 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05660525's enrollment target sits among peer trials
768 33rd of 188 higher than 156 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05119556 · 768 participants · NA
Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease
- NCT05404750 · 768 participants
Harm Reduction in HIV Primary Care for PLWH Who Use Drugs
- NCT06324357 · 768 participants · Phase 1
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- NCT07076485 · 768 participants · Phase 2
Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI